KIT and neoplasm: After freshly isolating KIT+ and KIT- cells from 3 human metastatic, imatinib-resistant GISTs with high ETV4 expression, we showed that ETV4 mRNA was minimal in KIT- (i.e., non-tumor) cells (Figure 1D).